The effect of dexamethasone on body and organ growth of normal and IGF- II-transgenic mice

Journal of Endocrinology

Volumn 163, Issue 3, 1999, Pages 543-552

  Rooman, R ^a,c   Koster, J G ^a   Bloemen, R ^a   Gresnigt, R ^a   Van Buul Offers, S C ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Huispost KC 030630 ^*  (Netherlands)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; BONE GROWTH; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; FEMALE; GROWTH INHIBITION; MOUSE; NONHUMAN; ORGAN GROWTH; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRAIN DIFFERENCE; TRANSGENIC MOUSE; WEIGHT REDUCTION;

EID: 0033389182     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1630543     Document Type: Article

References (57)

1. Allen DB, Mullen ML & Mullen B 1994 A meta-analysis of the effect of oral and inhaled corticosteroids on growth. Journal of Allergy and Clinical Immunology 93 967-976.
2. Altman A, Hochberg Z & Silbermann M 1992 Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse. Calcified Tissue International 51 298-304.
3. Blackburn A, Dressendorfer RA, Blum WF, Ehard M, Brem G, Strasburger CJ & Wolf E 1997 Interactions of insulin-like growth factor-II (IGF-II) and growth hormone in vivo: circulating levels of IGF-I and IGF-binding proteins in transgenic mice. European Journal of Endocrinology 137 701-708.
4. Breier BH, Gallaher BW & Gluckman PI) 1991 Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. Journal of Endocrinology 128 347-357.
5. van Buul-Offers SC 1996 Insulin-like growth tactor-II in the cycle of life. Biomedical Reviews 5 65-71.
6. van Buul-Offers SC, Hoogerbrugge CM, Branger J, Feijlbrief M & Van den Brande JL 1988 Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice. Hormone Research 29 229-236.
7. van Buul-Offers SC, Reijnen-Gresnigt MG, Hoogerbrugge CM, Bloenien RJ, Kuper CF & Van den Brande JL 1994 Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice. Endocrinology 135 977-985.
8. van Buul-Offers SC, De Haan K. Reijnen-Gresnigt MG. Meinsma D, Jansen M, Oei SL, Bonte EJ, Sussenbach JS & Van den Brande JL 1995 Overexpression of human IGF-II in transgenic mice causes increased growth of the thymus. Journal of Endocrinology 144 491-502.
9. Conlon MA, Francis GL, Tomas FM, Wallace JC, Howarth GS & Ballard FJ 1995 Continuous 14-day infusion of IGF-II increases the growth of normal female rats, but exhibits a lower potency than IGF-I. Journal of Endocrinology 144 91-98.
10. Douglas RG, Gluckman PD, Ball K, Breier B & Shaw JHF 1991 The effects of infusion of insulin-like growth factor (IGF)-I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs. Journal of Clinical Investigation 88 614-622.
11. Franco P, Marelli O, Lattuada D, Locatelli V, Cocchi D & Muller EE 1990 Influence of growth hormone on the immunosuppressive effect of prednisolone in mice. Acta Endocrinologica 123 339-344.
12. Frolik CA, Ellis LF & Williams DC 1998 Isolation and characterization of insulin-like growth factor-II from human bone. Biochemical and Biophysical Research Communications 151 1011-1018.
13. Geenen V, Achour I, Robert F, Vandersmissen E, Sodoyez JC, Defresne MP, Boniver J, Lefebvre PJ & Franchimont P 1993 Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus 21 115-127.
14. Giustina A & Wehrenberg WB 1992 The role of glucocorticoids in the regulation of growth hormone secretion. Trends in Endocrinology and Metabolism 3 306-311.
15. Glasscock GF, Hein AN, Miller JA, Hintz RL & Rosenfeld RG 1992 Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat. Endocrinology 130 203-210.
16. Gluckman PD & Ambler GR 1993 What is the function of circulating insulin-like growth factor-2 in postnatal life? Molecular and Cellular Endocrinology 92 C1-C3.
17. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S & Binoux M 1986 Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Analytical Biochemistry 154 138-143.
18. Hughes PCR & Tanner JM 1970 A longitudinal study of the growth of the blackhooded rat: methods of measurement and rates of growth for skull, limbs, pelvis, nose-rump and tail lengths. Journal of Anatomy 106 349-370.
19. King APJ & Carter-Su C 1995 Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts. Endocrinology 136 4796-4803.
20. Klaus G, Jux C, Leiber K, Hugel U & Mehls O 1996 Interaction between insulin-like growth factor I, growth hormone, 1 alfa, 25-dihydroxyvitamin D3 and steroids on epiphyseal chondrocytes. Acta Paediatrica Scandinavica (Suppl) 417 69-71.
21. Koea JB, Dreier BH, Shaw JHF & Gluckman PD 1992 A possible role for IGF-II: evidence in sheep for in vivo regulation of IGF-I-mediated protein anabolism. Endocrinology 130 2423-2425.
22. Kooijman R, van Buul-Offers SG, Scholtens LE, Schuurman H-J, Van den Brande LJ & Zegers BMJ 1995 T cell development in insulin-like growth factor-II-transgenic mice. Journal of Immunology 154 5736-5745.
23. Laron Z, Arie BZ & Kende S 1963 Effectiveness of growth hormone to prevent the alterations produced by 6-methylprednisolone (Medrol) on the growing bone in rats. Endocrinology 72 470-473.
24. Li J, Saunders JC, Fowden AL, Dauncey MJ & Gilmour RS 1998 Transcriptional regulation of insulin-like growth factor-II gene expression by cortisol in fetal sheep during late gestation. Journal of Biological Chemistry 273 10586-10593.
25. Lo HC, Hinton PS, Yng H, Unterman TG & Ney DM 1996 Insulin-like growth factor I, hut not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats. Journal of Parenteral and Enteral Nutrition 20 171-177.
26. Luo J & Murphy LJ 1989 Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology 125 165-171.
27. Luo J & Murphy LJ 1990 Regulation of insulin-like growth factor binding protein-3 expression by dexamethasone. Molecule and Cellular Endocrinology 74 213-219.
28. Miell JP, Buchanan CR, Norman MR, Maheshwari HG & Blum WF 1994 The evolution of changes in immunoreactible serum insulin-like growth factors (IGFs), IGF binding proteins, circulating growth hormone (GH) and GH binding protein as a result of short term dexamethasone treatment. Journal of Endocrinology 142 547-554.
29. Mohan S & Baylink DJ 1996 Insulin-like growth factor system components and the coupling of bone formation to resorption. Hormone Research 45 59-62.
30. Mohan S, Jennings JC, Linkhart TA & Baylink DJ 1988 Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochimica et Biophysica Acta 966 44-55.
31. Movat HZ 1955 Demonstration of all connective tissue elements in a single section: pentachrome stains. Archives of Pathology 60 289-295.
32. Ortoft G, Gronbaek H & Oxlund H 1998 Growth hormone administration can improve growth in glucocorticoid-injected rats without affecting the lymphocytopenic effect of the glucocorticoid. Growth Hormone and IGF Research 8 251-264.
33. Orwoll ES & Klein RF 1995 Osteoporosis in men. Endotrine Reviews 16 87-116.
34. Ren-Qiu Q, Ruelicke T, Hassam S, Haselbacher GK & Schoenle EJ 1993 Systemic effects of insulin-like growth factor-II produced and released from Wilms tumour tissue. European Journal of Pediatrics 152 102-1116.
35. Rivkees SA, Danon M & Herrin J 1994 Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure. Journal of Pediatrics 125 322-325.
36. Robinson GM, Spencer GSG, Berry CJ, Dobbie PM, Hodgkinson SC & Bass JJ 1993 Evidence of a role for growth hormone, but not for insulin-like growth tactors-I or -II in the growth of the neonatal rat. Biology of the Neonate 64 158-165.
37. Rodgers DB, Strack AM, Dallman MF, Hwa L & Nicoll CS 1995 Corticosterone regulation of insulin-like growth factor I, IGF binding proteins and growth in streptozotocin-induced diabetic rats. Diabetes 44 1420-1425.
38. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K & Hintz R 1994 Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II-transgenic mice. Journal of Biological Chemistry 269 13779-13784.
39. Schoenle E, Zapf J, Hauri C, Steiner T & Froesch ER 1985 Companson of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinologica 108 167-174.
40. Shaar CJ, Tinsley FC, Smith MC, Clemens JA & Neubauer BL 1989 Recombinant DNA-derived human insulin-like growth factor II (hIGF-II) stimulates growth in hypophysectomized rats. Endocrine Research 15 403-411.
41. Shinar DM, Endo N, Halperin D, Rodan GA & Weinreb M 1993 Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology 132 1158-1167.
42. Silbermann M & Kadar T 1977 Quantitative changes in the cellular population of the growth plate in triamcinolone-treated mice. Acta Anatomica 98 396-400.
43. Silbermann M, Kleinhaus U, Livne E & Kedar T 1976 Retardation of bone growth in triamcinolone-treated mice. Journal of Anatomy 121 515-535.
44. Simmons DJ & Kunin AS 1967 Autoradiographic and biochemical investigations of the effect of cortisone on the bones of the rat. Clinical Orthopedics and Related Research 551 201-215.
45. Smeets T & van Buul-Offers SC 1983a A morphological study of the development of the tibial proximal epiphysis and growth plate of normal and dwarfed Snell mice. Growth 47 145-158.
46. Smeets T & van Buul-Offers SC 1983b The influence of growth hormone, somatomedins, prolactin and thyroxine on the morphology of the proximal tibial epiphysis and growth plate of Snell dwarf mice. Growth 47 160-173.
47. Unterman TG & Phillips LS 1985 Glucocorticoid effects on somatomedins and somatomedin inhibitors. Journal of Clinical Endocrinology and Metabolism 61 618-626.
48. van der Ven LTM, Roholl PJM, Reijnen-Gresnigt MG, Bloemen RJ & van Buul-Offers SC 1997 Expression of insulin-like growth factor-II (IGF-II) and histological changes in the thymus and spleen of transgenic mice overexpressing IGF-II. Histochemistry and Cell Biology 107 193-203.
49. Wang E, Wang J, Chin E, Zhou J & Bondy CA 1995 Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis. Endocrinology 136 2741-2751.
50. Ward A, Bates P, Fisher R, Richardson L & Graham CF 1994 Disproportionate growth in mice with Igf-2 transgenes. Proceedings of the National Academy of Sciences of the USA 91 10365-10369.
51. Wergedal JE, Mohan S, Lundy M & Baylink DJ 1990 Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. Journal of Bone and Mineral Research 5 179-186.
52. Wilson DM, Thomas JA, Hamm TE, Wyche J, Hintz RL & Rosenfeld RG 1987 Transplantation of insulin-like growth factor-II-secreting tumors into nude rodents. Endocrinology 120 1896-1901.
53. Wolf E, Kramer R, Blum WF, Foll J & Brem G 1994 Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology 135 1877-1886.
54. Wolf E, Rapp K, Blum WF, Kolb H & Brem G 1995 Skeletal growth of transgenic mice with elevated levels of circulating insulin-like growth factor-II. Growth Regulation 5 177-184.
55. Wolf E, Hoeflich A & Lahm H 1998 What is the function of IGF-II in postnatal life? Answers from transgenic mouse models. Growth Hormone and IGF Research 8 185-193.
56. Yang H, Grahn M, Schalch DS & Ney DM 1994 Anabolic effects of IGF-I confused with total parenteral nutrition in dexamethasone-treated rats. American Journal of Physiology, Endocrinology and Metabolism 266 E690-E698.
57. Zucker RM, Elstein KH, Thomas DJ & Rogers JM 1994 Tributyltin and dexamethasone induce apoptosis in rat thymocytes by mutually antagonistic mechanisms. Toxicology and Applied Pharmacology 127 163-170.